These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 20483759

  • 1. TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy.
    Tsai YG, Yang KD, Niu DM, Chien JW, Lin CY.
    J Immunol; 2010 Jun 15; 184(12):7229-37. PubMed ID: 20483759
    [Abstract] [Full Text] [Related]

  • 2. Allergen-specific immunotherapy enhances CD8+  CD25+  CD137+ regulatory T cells and decreases nasal nitric oxide.
    Tsai YG, Yang KD, Wen YS, Hung CH, Chien JW, Lin CY.
    Pediatr Allergy Immunol; 2019 Aug 15; 30(5):531-539. PubMed ID: 30968455
    [Abstract] [Full Text] [Related]

  • 3. Responses of CD4(+) CD25(+) Foxp3(+) and IL-10-secreting type I T regulatory cells to cluster-specific immunotherapy for allergic rhinitis in children.
    Lou W, Wang C, Wang Y, Han D, Zhang L.
    Pediatr Allergy Immunol; 2012 Mar 15; 23(2):140-9. PubMed ID: 22192331
    [Abstract] [Full Text] [Related]

  • 4. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
    Kiniwa Y, Miyahara Y, Wang HY, Peng W, Peng G, Wheeler TM, Thompson TC, Old LJ, Wang RF.
    Clin Cancer Res; 2007 Dec 01; 13(23):6947-58. PubMed ID: 18056169
    [Abstract] [Full Text] [Related]

  • 5. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease.
    Chen X, Zhou B, Li M, Deng Q, Wu X, Le X, Wu C, Larmonier N, Zhang W, Zhang H, Wang H, Katsanis E.
    Clin Immunol; 2007 Apr 01; 123(1):50-9. PubMed ID: 17234458
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The functional insufficiency of human CD4+CD25 high T-regulatory cells in allergic asthma is subjected to TNF-alpha modulation.
    Lin YL, Shieh CC, Wang JY.
    Allergy; 2008 Jan 01; 63(1):67-74. PubMed ID: 18053016
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.
    Vocanson M, Rozieres A, Hennino A, Poyet G, Gaillard V, Renaudineau S, Achachi A, Benetiere J, Kaiserlian D, Dubois B, Nicolas JF.
    J Allergy Clin Immunol; 2010 Aug 01; 126(2):280-9, 289.e1-7. PubMed ID: 20624644
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of house dust mite immunotherapy on transforming growth factor beta1-producing T cells in asthmatic children.
    Ajduk J, Marinic I, Aberle N, Rabatic S, Gagro A.
    Ann Allergy Asthma Immunol; 2008 Apr 01; 100(4):314-22. PubMed ID: 18450115
    [Abstract] [Full Text] [Related]

  • 17. Induction of IL-10+ CD4+ CD25+ regulatory T cells with decreased NF-κB expression during immunotherapy.
    Tsai YG, Chiou YL, Chien JW, Wu HP, Lin CY.
    Pediatr Allergy Immunol; 2010 Feb 01; 21(1 Pt 2):e166-73. PubMed ID: 19682278
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.